NovaBridge Biosciences
Giva
first-line treatment of gastric cancer
Countdown
177days
Catalyst readout · ~ Dec 31, 2026 estimated
What's at stake
A key catalyst for Giva (first-line treatment of gastric cancer) is expected ~ Dec 31, 2026.
Primary source
· SEC 6-K
verified 13h ago
“Giva PFS data from Phase 2 study for 1L treatment of GEA in combo with chemo + PD-1”